By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Antibe Therapeutics Inc. 

1063 King St. West
Suite 210
Hamilton  Ontario  L8S 4S3  Canada
Phone: 905-515-6132 Fax: 905-528-9862



Company News
Antibe Therapeutics (ATE.V) Announces Payment In Kind Election 10/17/2016 1:21:38 PM
Antibe Therapeutics (ATE.V) Confirms Non-Addictive Properties For Its Second Pipeline Drug, ATB-352, A Potent, Non-Addictive Pain-Killer 10/17/2016 1:10:42 PM
Antibe Therapeutics (ATE.V) Announces Launch Of Strategic Growth Initiative In The U.S. Market For Dental Biologics 10/11/2016 11:01:09 AM
Antibe Therapeutics (ATE.V) Release: ATB-346 Shows Promising Results In Experimental Melanoma 9/22/2016 11:47:17 AM
Antibe Therapeutics (ATE.V) To Present At 2016 Rodman & Renshaw Global Investment Conference 9/7/2016 2:08:08 PM
Antibe Therapeutics (ATE.V) Reports Q1 2017 Interim Financial And Operating Results 8/30/2016 1:05:52 PM
Antibe Therapeutics (ATE.V) Announces The Launch Of Neomem FlexPlus, A High-Performance Barrier Membrane For Oral Surgery 8/16/2016 10:18:00 AM
Antibe Therapeutics (ATE.V) Announces Successful Phase 2 Trial Of ATB-346 In Osteoarthritis 8/8/2016 10:28:09 AM
Antibe Therapeutics (ATE.V) Reports 2016 Year-End Financial And Operating Results 8/1/2016 11:29:26 AM
Antibe Therapeutics (ATE.V) Announces the Appointment of New Board Member and Provides Update on Phase 2 Trial of ATB-346 7/19/2016 11:46:32 AM